Thereport has been added to ResearchAndMarkets.com’s offering.
The global eye health supplements market is expected to grow at a compound annual growth rate of 5.87% over the forecast period to reach a market size of US$2,351.088 million in 2026 from US$1,669.556 million in 2020.
Eye health supplements refer to all those nutritional products that help to maintain eye health and reduce the effects of several eye disorders. These supplements come in the form of liquid drops, soft gels, capsules, and others. The global eye supplements market is projected to amplify at a significant rate during the forecast period. The key factors supporting the market growth include the globally growing awareness regarding the intake of eye health supplements and the growing prevalence of eye disorders. In addition, the market is also projected to witness a growth on account of the increasing myopic population in many parts of the world. Similarly, a growing geriatric population is also propelling the business growth opportunities for the market players over the forecast period since old aged people are more susceptible to eye disorders such as age-related macular degeneration (AMD) and diabetic retinopathy.
Thus, a growth in the number of diabetic people globally also plays a significant role in shaping up the market growth during the given time frame. On the other hand, the increasing participation by the market players also supports the market growth significantly since active participation by major players operating in the market is actively participating in the form of increased investments in the R&D for the launch of new and enhanced products, which in turn, represents the growth potential of the market. Also, the expansion of distribution channels and the movement of market players to online channels to capture a greater market share further provides an impetus to the market growth in the near future.
The outbreak of the novel coronavirus disease is projected to have a significant positive impact on the market growth since changing working policies have led a majority of people to stay at home has further led to an increase in the number of hours working in front of systems. This, combined with the keen focus to improve and maintain eye health amid the pandemic has further supplemented the market growth, particularly during the short run.
The segmentation of the global eye health supplements market has been done into type, form, indication, distribution channel, and geography. On the basis of type, the market has been classified as vitamins, minerals, fatty acids, and others. By form, the segmentation has been done as gels, capsules, liquid, and others. By indication, the classification of the market has been done as cataract, age-related macular degeneration, dry eye syndrome, and others. By the distribution channel, the market has been segmented into online and offline. Geographically, the global eye health supplements market has been segmented into North America, South America, Europe, Middle East and Africa, and the Asia Pacific.
Key Topics Covered:
1.1. Market Definition
1.2. Market Segmentation
2. Research Methodology
2.1. Research Data
3. Executive Summary
3.1. Research Highlights
4. Market Dynamics
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.4. Industry Value Chain Analysis
5. Global Eye Health Supplements Market Analysis, By Type
5.4. Fatty Acids
6. Global Eye Health Supplements Market Analysis, By Form
7. Global Eye Health Supplements Market Analysis, By Indication
7.3. Age-Related Macular Degeneration (AMD)
7.4. Dry Eye Syndrome
8. Global Eye Health Supplements Market Analysis, By Distribution Channel
9. Global Eye Health Supplements Market Analysis, by Geography
9.2. North America
9.3. South America
9.5. The Middle East and Africa
9.6. Asia Pacific
10. Competitive Environment and Analysis
10.1. Major Players and Strategy Analysis
10.2. Emerging Players and Market Lucrativeness
10.3. Mergers, Acquisitions, Agreements, and Collaborations
10.4. Vendor Competitiveness Matrix
11. Company Profiles
11.1. Nature’s Bounty Co.
11.2. Amway Corporation
11.3. Bausch & Lomb Incorporated
11.4. Vitabiotics Ltd.
11.5. Kemin Industries
11.6. ZeaVision LLC
11.7. Pfizer Inc.
11.8. Alliance Pharma PLC
11.9. OmniActive Health Technologies
For more information about this report visit
View source version on businesswire.com:
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900